Tributyl(5,6-dihydro-4H-pyran-2-yl)stannane
Product Information
Molecular Formula
C17H34OSn
Molecular Weight
373.16
Description
Tributyl(5,6-dihydro-4H-pyran-2-yl)stannane is a highly significant organic compound widely employed in the biomedical industry. Extensive research has been conducted to explore its antitumor efficacy, which exhibits promising characteristics in effectively hampering tumor proliferation. Moreover, this compound manifests remarkable antimicrobial activity, thereby demonstrating its intrinsic capacity as a potential intervention strategy against a diverse array of infectious ailments.
Synonyms
tributyl(3,4-dihydro-2H-pyran-6-yl)stannane; Stannane, tributyl(3,4-dihydro-2H-pyran-6-yl)-; 5,6-dihydro-2-(tributylstannyl)-4H-pyran; tributyl-(5,6-dihydro-4H-pyran-2-yl)-stannane
IUPAC Name
tributyl(3,4-dihydro-2H-pyran-6-yl)stannane
SMILES
CCCC[Sn](CCCC)(CCCC)C1=CCCCO1
InChI
InChI=1S/C5H7O.3C4H9.Sn/c1-2-4-6-5-3-13*1-3-4-2/h2H,1,3,5H23*1,3-4H2,2H3
InChI Key
ZQMLPLBDZBCQCV-UHFFFAOYSA-N
Flash Point
Not applicable
Purity
95%
Density
1.119 g/mL at 25 °C
Refractive Index
n20/D 1.495
Safety Information
Hazards
H301 - H312 - H315 - H319 - H372 - H410
Precautionary Statement
P273 - P280 - P301 + P310 + P330 - P302 + P352 + P312 - P305 + P351 + P338 - P314
Computed Properties
Hydrogen Bond Donor Count
0
Hydrogen Bond Acceptor Count
1
Rotatable Bond Count
10
Exact Mass
374.163168 g/mol
Monoisotopic Mass
374.163168 g/mol
Topological Polar Surface Area
9.2Ų
Heavy Atom Count
19
Formal Charge
0
Complexity
238
Isotope Atom Count
0
Defined Atom Stereocenter Count
0
Undefined Atom Stereocenter Count
0
Defined Bond Stereocenter Count
0
Undefined Bond Stereocenter Count
0
Covalently-Bonded Unit Count
1
Compound Is Canonicalized
Yes
Patents
| Publication Number | Title | Priority Date |
|---|---|---|
| AU-2008281877-A1 | The use of benzamide derivatives for the treatment of CNS disorders | 2007-08-02 |
| CA-2695071-A1 | The use of benzamide derivatives for the treatment of cns disorders | 2007-08-02 |
| EP-2182935-A1 | The use of benzamide derivatives for the treatment of cns disorders | 2007-08-02 |
| JP-2010535172-A | Use of benzamide derivatives for the treatment of CNS disorders | 2007-08-02 |
| KR-20100039429-A | Use of Benzamide Derivatives for the Treatment of CNS Disease | 2007-08-02 |
| US-2009036420-A1 | Benzamide derivatives and their use for treating cns disorders | 2007-08-02 |
| WO-2009016088-A1 | The use of benzamide derivatives for the treatment of cns disorders | 2007-08-02 |
| AU-2006318640-B2 | Beta-secretase modulators and methods of use | 2005-11-21 |
| US-2007185103-A1 | Beta-secretase modulators and methods of use | 2005-11-21 |
| US-2011118250-A1 | Beta-secretase modulators and methods of use | 2005-11-21 |
